-
Johnson & Johnson Reports $100 Million in Quarterly Sales From Covid Vaccine
J&J’s financial results come as the company’s Covid-19 vaccine has been put on pause in the United States.
-
U.S. Covid Vaccination Obstacle Shifts Towards Lack of Demand From Scarce Supply, Warns Doctor
Dr. Carlos Del Rio explains what the U.S. needs to do in order to see Covid cases dramatically drop in May.
-
CDC Says Fewer Than 6,000 Americans Have Contracted Covid After Being Fully Vaccinated
U.S. officials have confirmed fewer than 6,000 cases of Covid-19 in fully vaccinated Americans, just 0.007% of the 84 million Americans with full protection.
-
J&J Asked Pfizer and Moderna to Help Study Blood Clot Risks But They Declined, Report Says
J&J asked Covid vaccine rivals Pfizer and Moderna to join a study looking into the potential risk of blood clots, The Wall Street Journal reported.
-
Biden Administration Is Planning for Possible Covid Vaccine Booster Shots
The Biden administration is preparing for the potential need for Covid-19 vaccine booster shots, though nothing is certain, a top U.S. official said.
-
More Young People Are Getting Hospitalized as Covid Variants Spread. Here's What We Know
CDC Director Dr. Rochelle Walensky said earlier this month hospitals are seeing more younger adults admitted with Covid-19 as more contagious variants spread.
-
Merck Ends Development of Covid Drug It Acquired From OncoImmune
Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
-
CDC Panel Postpones Decision on J&J Vaccine While It Investigates Rare But Serious Blood-Clot Issue
A CDC panel on Wednesday postponed a decision on J&J’s Covid vaccine while it investigates cases of six women developing a rare blood-clotting disorder.
-
Watch Live: CDC Panel Debates Use of J&J Covid Vaccine After Rare Blood Clot Issue Affects 6 Women
The Advisory Committee on Immunization Practices will review data on the women who developed a rare blood-clotting disorder.
-
White House Says U.S. Is Working to Accelerate Doses of Pfizer, Moderna Covid Vaccines
Jeff Zients said the FDA’s recommended pause on J&J’s vaccine would not have a “significant impact” on the administration’s vaccination program.
-
Dr. Anthony Fauci Explains What the U.S. Pause on J&J's Covid Vaccine Means
Dr. Fauci said the pause will give U.S. health regulators the time they need to thoroughly investigate how six women developed a rare blood clotting disorder.
-
Pausing Use of J&J Covid Vaccine Will Not Affect Timeline of Getting U.S. Vaccinated, Says Doctor
Dr. Ashish Jha explains the impact of temporarily pausing use of the J&J Covid vaccine, and why he thinks it may bolster confidence in Covid vaccines.
-
Pausing Use of J&J Covid Vaccine Will Not Affect Timeline of Getting U.S. Vaccinated, Says Doctor
Dr. Ashish Jha explains the impact of temporarily pausing use of the J&J Covid vaccine, and why he thinks it may bolster confidence in Covid vaccines.
-
Moderna Says New Data Shows Its Covid Vaccine Is More Than 90% Effective Against Virus Six Months After Second Shot
Moderna said Tuesday that new data shows its vaccine is more than 90% effective at protecting against Covid-19 up to six months after the second dose.
-
Panicked Patients Call Doctors as Covid Vaccine Hesitancy Rises With J&J Blood Clot Issue
The warning from U.S. officials to states is likely to fuel more hesitancy in taking J&J’s shot and other vaccines, threatening to stall the pandemic recovery.
-
Live: FDA and CDC Hold Press Briefing After Pausing Use of J&J Covid Vaccine
The FDA and CDC are holding a joint press briefing on the J&J vaccine.
-
WHO Says Covid Pandemic Is Growing ‘Exponentially' at More Than 4.4 Million New Cases a Week
Maria Van Kerkhove, the agency’s technical lead for Covid-19, said “we’re in a critical point of the pandemic.”
-
Covid Cases Overwhelm Michigan Health System, Gov. Whitmer Urges Residents to Stay Home
The state health department is tracking 991 Covid outbreaks across Michigan, Chief Medical Executive Dr. Joneigh Khaldun said.
-
Regeneron to Request FDA Clearance to Use Covid Antibody Drug as a Preventative Treatment
Regeneron said a phase three clinical trial of the drug reduced the risk of symptomatic infections in individuals by 81%.
-
WHO Says More Than 87% of the World's Covid Vaccine Supply Has Gone to Higher-Income Countries
On average, 1 in 4 people in high-income countries have received a coronavirus vaccine, compared with just 1 in more than 500 in low-income countries, WHO says.